Global Artificial Intelligence (AI) in Cancer Market Insights, Forecast to 2029
This report presents an overview of global market for Artificial Intelligence (AI) in Cancer market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Artificial Intelligence (AI) in Cancer, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Artificial Intelligence (AI) in Cancer, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Artificial Intelligence (AI) in Cancer revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Artificial Intelligence (AI) in Cancer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Artificial Intelligence (AI) in Cancer revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including IBM, Microsoft, NVIDIA, Intel, GE Healthcare, Johnson & Johnson, Cancer Center.ai, Digital Reasoning and Varian Medical Systems, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Artificial Intelligence (AI) in Cancer in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence (AI) in Cancer companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence (AI) in Cancer revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Artificial Intelligence (AI) in Cancer, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Artificial Intelligence (AI) in Cancer, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Artificial Intelligence (AI) in Cancer revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Artificial Intelligence (AI) in Cancer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Artificial Intelligence (AI) in Cancer revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including IBM, Microsoft, NVIDIA, Intel, GE Healthcare, Johnson & Johnson, Cancer Center.ai, Digital Reasoning and Varian Medical Systems, etc.
By Company
- IBM
- Microsoft
- NVIDIA
- Intel
- GE Healthcare
- Johnson & Johnson
- Cancer Center.ai
- Digital Reasoning
- Varian Medical Systems
- Niramai
- Densitas
- MammoScreen
- MVision AI
- Volpara
- LungLifeAI
- Surgery
- Radiotherapy
- Chemotherapy
- Immunotherapy
- Phototherapy
- Gene Therapy
- Sonodynamic Therapy
- Diagnosis
- Therapy
- Prognosis
- Health Management
- Research
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Artificial Intelligence (AI) in Cancer in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence (AI) in Cancer companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence (AI) in Cancer revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Surgery
1.2.3 Radiotherapy
1.2.4 Chemotherapy
1.2.5 Immunotherapy
1.2.6 Phototherapy
1.2.7 Gene Therapy
1.2.8 Sonodynamic Therapy
1.3 Market by Application
1.3.1 Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Diagnosis
1.3.3 Therapy
1.3.4 Prognosis
1.3.5 Health Management
1.3.6 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Artificial Intelligence (AI) in Cancer Market Perspective (2018-2029)
2.2 Global Artificial Intelligence (AI) in Cancer Growth Trends by Region
2.2.1 Artificial Intelligence (AI) in Cancer Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Intelligence (AI) in Cancer Historic Market Size by Region (2018-2023)
2.2.3 Artificial Intelligence (AI) in Cancer Forecasted Market Size by Region (2024-2029)
2.3 Artificial Intelligence (AI) in Cancer Market Dynamics
2.3.1 Artificial Intelligence (AI) in Cancer Industry Trends
2.3.2 Artificial Intelligence (AI) in Cancer Market Drivers
2.3.3 Artificial Intelligence (AI) in Cancer Market Challenges
2.3.4 Artificial Intelligence (AI) in Cancer Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Artificial Intelligence (AI) in Cancer by Players
3.1.1 Global Artificial Intelligence (AI) in Cancer Revenue by Players (2018-2023)
3.1.2 Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Intelligence (AI) in Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Artificial Intelligence (AI) in Cancer, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Artificial Intelligence (AI) in Cancer Market Concentration Ratio
3.4.1 Global Artificial Intelligence (AI) in Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence (AI) in Cancer Revenue in 2022
3.5 Global Key Players of Artificial Intelligence (AI) in Cancer Head office and Area Served
3.6 Global Key Players of Artificial Intelligence (AI) in Cancer, Product and Application
3.7 Global Key Players of Artificial Intelligence (AI) in Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 ARTIFICIAL INTELLIGENCE (AI) IN CANCER BREAKDOWN DATA BY TYPE
4.1 Global Artificial Intelligence (AI) in Cancer Historic Market Size by Type (2018-2023)
4.2 Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Type (2024-2029)
5 ARTIFICIAL INTELLIGENCE (AI) IN CANCER BREAKDOWN DATA BY APPLICATION
5.1 Global Artificial Intelligence (AI) in Cancer Historic Market Size by Application (2018-2023)
5.2 Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Artificial Intelligence (AI) in Cancer Market Size (2018-2029)
6.2 North America Artificial Intelligence (AI) in Cancer Market Size by Type
6.2.1 North America Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023)
6.2.2 North America Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029)
6.2.3 North America Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
6.3 North America Artificial Intelligence (AI) in Cancer Market Size by Application
6.3.1 North America Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023)
6.3.2 North America Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029)
6.3.3 North America Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
6.4 North America Artificial Intelligence (AI) in Cancer Market Size by Country
6.4.1 North America Artificial Intelligence (AI) in Cancer Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Artificial Intelligence (AI) in Cancer Market Size by Country (2018-2023)
6.4.3 North America Artificial Intelligence (AI) in Cancer Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 EUROPE
7.1 Europe Artificial Intelligence (AI) in Cancer Market Size (2018-2029)
7.2 Europe Artificial Intelligence (AI) in Cancer Market Size by Type
7.2.1 Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023)
7.2.2 Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029)
7.2.3 Europe Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
7.3 Europe Artificial Intelligence (AI) in Cancer Market Size by Application
7.3.1 Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023)
7.3.2 Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029)
7.3.3 Europe Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
7.4 Europe Artificial Intelligence (AI) in Cancer Market Size by Country
7.4.1 Europe Artificial Intelligence (AI) in Cancer Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2018-2023)
7.4.3 Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Artificial Intelligence (AI) in Cancer Market Size (2018-2029)
8.2 China Artificial Intelligence (AI) in Cancer Market Size by Type
8.2.1 China Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023)
8.2.2 China Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029)
8.2.3 China Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
8.3 China Artificial Intelligence (AI) in Cancer Market Size by Application
8.3.1 China Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023)
8.3.2 China Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029)
8.3.3 China Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Artificial Intelligence (AI) in Cancer Market Size (2018-2029)
9.2 Asia Artificial Intelligence (AI) in Cancer Market Size by Type
9.2.1 Asia Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023)
9.2.2 Asia Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029)
9.2.3 Asia Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
9.3 Asia Artificial Intelligence (AI) in Cancer Market Size by Application
9.3.1 Asia Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023)
9.3.2 Asia Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029)
9.3.3 Asia Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
9.4 Asia Artificial Intelligence (AI) in Cancer Market Size by Region
9.4.1 Asia Artificial Intelligence (AI) in Cancer Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Artificial Intelligence (AI) in Cancer Market Size by Region (2018-2023)
9.4.3 Asia Artificial Intelligence (AI) in Cancer Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Type
10.2.1 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Application
10.3.1 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Country
10.4.1 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 IBM
11.1.1 IBM Company Details
11.1.2 IBM Business Overview
11.1.3 IBM Artificial Intelligence (AI) in Cancer Introduction
11.1.4 IBM Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.1.5 IBM Recent Developments
11.2 Microsoft
11.2.1 Microsoft Company Details
11.2.2 Microsoft Business Overview
11.2.3 Microsoft Artificial Intelligence (AI) in Cancer Introduction
11.2.4 Microsoft Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.2.5 Microsoft Recent Developments
11.3 NVIDIA
11.3.1 NVIDIA Company Details
11.3.2 NVIDIA Business Overview
11.3.3 NVIDIA Artificial Intelligence (AI) in Cancer Introduction
11.3.4 NVIDIA Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.3.5 NVIDIA Recent Developments
11.4 Intel
11.4.1 Intel Company Details
11.4.2 Intel Business Overview
11.4.3 Intel Artificial Intelligence (AI) in Cancer Introduction
11.4.4 Intel Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.4.5 Intel Recent Developments
11.5 GE Healthcare
11.5.1 GE Healthcare Company Details
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Artificial Intelligence (AI) in Cancer Introduction
11.5.4 GE Healthcare Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.5.5 GE Healthcare Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Artificial Intelligence (AI) in Cancer Introduction
11.6.4 Johnson & Johnson Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.6.5 Johnson & Johnson Recent Developments
11.7 Cancer Center.ai
11.7.1 Cancer Center.ai Company Details
11.7.2 Cancer Center.ai Business Overview
11.7.3 Cancer Center.ai Artificial Intelligence (AI) in Cancer Introduction
11.7.4 Cancer Center.ai Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.7.5 Cancer Center.ai Recent Developments
11.8 Digital Reasoning
11.8.1 Digital Reasoning Company Details
11.8.2 Digital Reasoning Business Overview
11.8.3 Digital Reasoning Artificial Intelligence (AI) in Cancer Introduction
11.8.4 Digital Reasoning Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.8.5 Digital Reasoning Recent Developments
11.9 Varian Medical Systems
11.9.1 Varian Medical Systems Company Details
11.9.2 Varian Medical Systems Business Overview
11.9.3 Varian Medical Systems Artificial Intelligence (AI) in Cancer Introduction
11.9.4 Varian Medical Systems Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.9.5 Varian Medical Systems Recent Developments
11.10 Niramai
11.10.1 Niramai Company Details
11.10.2 Niramai Business Overview
11.10.3 Niramai Artificial Intelligence (AI) in Cancer Introduction
11.10.4 Niramai Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.10.5 Niramai Recent Developments
11.11 Densitas
11.11.1 Densitas Company Details
11.11.2 Densitas Business Overview
11.11.3 Densitas Artificial Intelligence (AI) in Cancer Introduction
11.11.4 Densitas Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.11.5 Densitas Recent Developments
11.12 MammoScreen
11.12.1 MammoScreen Company Details
11.12.2 MammoScreen Business Overview
11.12.3 MammoScreen Artificial Intelligence (AI) in Cancer Introduction
11.12.4 MammoScreen Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.12.5 MammoScreen Recent Developments
11.13 MVision AI
11.13.1 MVision AI Company Details
11.13.2 MVision AI Business Overview
11.13.3 MVision AI Artificial Intelligence (AI) in Cancer Introduction
11.13.4 MVision AI Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.13.5 MVision AI Recent Developments
11.14 Volpara
11.14.1 Volpara Company Details
11.14.2 Volpara Business Overview
11.14.3 Volpara Artificial Intelligence (AI) in Cancer Introduction
11.14.4 Volpara Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.14.5 Volpara Recent Developments
11.15 LungLifeAI
11.15.1 LungLifeAI Company Details
11.15.2 LungLifeAI Business Overview
11.15.3 LungLifeAI Artificial Intelligence (AI) in Cancer Introduction
11.15.4 LungLifeAI Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.15.5 LungLifeAI Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Surgery
1.2.3 Radiotherapy
1.2.4 Chemotherapy
1.2.5 Immunotherapy
1.2.6 Phototherapy
1.2.7 Gene Therapy
1.2.8 Sonodynamic Therapy
1.3 Market by Application
1.3.1 Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Diagnosis
1.3.3 Therapy
1.3.4 Prognosis
1.3.5 Health Management
1.3.6 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Artificial Intelligence (AI) in Cancer Market Perspective (2018-2029)
2.2 Global Artificial Intelligence (AI) in Cancer Growth Trends by Region
2.2.1 Artificial Intelligence (AI) in Cancer Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Intelligence (AI) in Cancer Historic Market Size by Region (2018-2023)
2.2.3 Artificial Intelligence (AI) in Cancer Forecasted Market Size by Region (2024-2029)
2.3 Artificial Intelligence (AI) in Cancer Market Dynamics
2.3.1 Artificial Intelligence (AI) in Cancer Industry Trends
2.3.2 Artificial Intelligence (AI) in Cancer Market Drivers
2.3.3 Artificial Intelligence (AI) in Cancer Market Challenges
2.3.4 Artificial Intelligence (AI) in Cancer Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Artificial Intelligence (AI) in Cancer by Players
3.1.1 Global Artificial Intelligence (AI) in Cancer Revenue by Players (2018-2023)
3.1.2 Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Intelligence (AI) in Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Artificial Intelligence (AI) in Cancer, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Artificial Intelligence (AI) in Cancer Market Concentration Ratio
3.4.1 Global Artificial Intelligence (AI) in Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence (AI) in Cancer Revenue in 2022
3.5 Global Key Players of Artificial Intelligence (AI) in Cancer Head office and Area Served
3.6 Global Key Players of Artificial Intelligence (AI) in Cancer, Product and Application
3.7 Global Key Players of Artificial Intelligence (AI) in Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 ARTIFICIAL INTELLIGENCE (AI) IN CANCER BREAKDOWN DATA BY TYPE
4.1 Global Artificial Intelligence (AI) in Cancer Historic Market Size by Type (2018-2023)
4.2 Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Type (2024-2029)
5 ARTIFICIAL INTELLIGENCE (AI) IN CANCER BREAKDOWN DATA BY APPLICATION
5.1 Global Artificial Intelligence (AI) in Cancer Historic Market Size by Application (2018-2023)
5.2 Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Artificial Intelligence (AI) in Cancer Market Size (2018-2029)
6.2 North America Artificial Intelligence (AI) in Cancer Market Size by Type
6.2.1 North America Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023)
6.2.2 North America Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029)
6.2.3 North America Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
6.3 North America Artificial Intelligence (AI) in Cancer Market Size by Application
6.3.1 North America Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023)
6.3.2 North America Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029)
6.3.3 North America Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
6.4 North America Artificial Intelligence (AI) in Cancer Market Size by Country
6.4.1 North America Artificial Intelligence (AI) in Cancer Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Artificial Intelligence (AI) in Cancer Market Size by Country (2018-2023)
6.4.3 North America Artificial Intelligence (AI) in Cancer Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 EUROPE
7.1 Europe Artificial Intelligence (AI) in Cancer Market Size (2018-2029)
7.2 Europe Artificial Intelligence (AI) in Cancer Market Size by Type
7.2.1 Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023)
7.2.2 Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029)
7.2.3 Europe Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
7.3 Europe Artificial Intelligence (AI) in Cancer Market Size by Application
7.3.1 Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023)
7.3.2 Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029)
7.3.3 Europe Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
7.4 Europe Artificial Intelligence (AI) in Cancer Market Size by Country
7.4.1 Europe Artificial Intelligence (AI) in Cancer Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2018-2023)
7.4.3 Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Artificial Intelligence (AI) in Cancer Market Size (2018-2029)
8.2 China Artificial Intelligence (AI) in Cancer Market Size by Type
8.2.1 China Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023)
8.2.2 China Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029)
8.2.3 China Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
8.3 China Artificial Intelligence (AI) in Cancer Market Size by Application
8.3.1 China Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023)
8.3.2 China Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029)
8.3.3 China Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Artificial Intelligence (AI) in Cancer Market Size (2018-2029)
9.2 Asia Artificial Intelligence (AI) in Cancer Market Size by Type
9.2.1 Asia Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023)
9.2.2 Asia Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029)
9.2.3 Asia Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
9.3 Asia Artificial Intelligence (AI) in Cancer Market Size by Application
9.3.1 Asia Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023)
9.3.2 Asia Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029)
9.3.3 Asia Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
9.4 Asia Artificial Intelligence (AI) in Cancer Market Size by Region
9.4.1 Asia Artificial Intelligence (AI) in Cancer Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Artificial Intelligence (AI) in Cancer Market Size by Region (2018-2023)
9.4.3 Asia Artificial Intelligence (AI) in Cancer Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Type
10.2.1 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Application
10.3.1 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Country
10.4.1 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 IBM
11.1.1 IBM Company Details
11.1.2 IBM Business Overview
11.1.3 IBM Artificial Intelligence (AI) in Cancer Introduction
11.1.4 IBM Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.1.5 IBM Recent Developments
11.2 Microsoft
11.2.1 Microsoft Company Details
11.2.2 Microsoft Business Overview
11.2.3 Microsoft Artificial Intelligence (AI) in Cancer Introduction
11.2.4 Microsoft Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.2.5 Microsoft Recent Developments
11.3 NVIDIA
11.3.1 NVIDIA Company Details
11.3.2 NVIDIA Business Overview
11.3.3 NVIDIA Artificial Intelligence (AI) in Cancer Introduction
11.3.4 NVIDIA Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.3.5 NVIDIA Recent Developments
11.4 Intel
11.4.1 Intel Company Details
11.4.2 Intel Business Overview
11.4.3 Intel Artificial Intelligence (AI) in Cancer Introduction
11.4.4 Intel Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.4.5 Intel Recent Developments
11.5 GE Healthcare
11.5.1 GE Healthcare Company Details
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Artificial Intelligence (AI) in Cancer Introduction
11.5.4 GE Healthcare Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.5.5 GE Healthcare Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Artificial Intelligence (AI) in Cancer Introduction
11.6.4 Johnson & Johnson Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.6.5 Johnson & Johnson Recent Developments
11.7 Cancer Center.ai
11.7.1 Cancer Center.ai Company Details
11.7.2 Cancer Center.ai Business Overview
11.7.3 Cancer Center.ai Artificial Intelligence (AI) in Cancer Introduction
11.7.4 Cancer Center.ai Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.7.5 Cancer Center.ai Recent Developments
11.8 Digital Reasoning
11.8.1 Digital Reasoning Company Details
11.8.2 Digital Reasoning Business Overview
11.8.3 Digital Reasoning Artificial Intelligence (AI) in Cancer Introduction
11.8.4 Digital Reasoning Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.8.5 Digital Reasoning Recent Developments
11.9 Varian Medical Systems
11.9.1 Varian Medical Systems Company Details
11.9.2 Varian Medical Systems Business Overview
11.9.3 Varian Medical Systems Artificial Intelligence (AI) in Cancer Introduction
11.9.4 Varian Medical Systems Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.9.5 Varian Medical Systems Recent Developments
11.10 Niramai
11.10.1 Niramai Company Details
11.10.2 Niramai Business Overview
11.10.3 Niramai Artificial Intelligence (AI) in Cancer Introduction
11.10.4 Niramai Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.10.5 Niramai Recent Developments
11.11 Densitas
11.11.1 Densitas Company Details
11.11.2 Densitas Business Overview
11.11.3 Densitas Artificial Intelligence (AI) in Cancer Introduction
11.11.4 Densitas Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.11.5 Densitas Recent Developments
11.12 MammoScreen
11.12.1 MammoScreen Company Details
11.12.2 MammoScreen Business Overview
11.12.3 MammoScreen Artificial Intelligence (AI) in Cancer Introduction
11.12.4 MammoScreen Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.12.5 MammoScreen Recent Developments
11.13 MVision AI
11.13.1 MVision AI Company Details
11.13.2 MVision AI Business Overview
11.13.3 MVision AI Artificial Intelligence (AI) in Cancer Introduction
11.13.4 MVision AI Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.13.5 MVision AI Recent Developments
11.14 Volpara
11.14.1 Volpara Company Details
11.14.2 Volpara Business Overview
11.14.3 Volpara Artificial Intelligence (AI) in Cancer Introduction
11.14.4 Volpara Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.14.5 Volpara Recent Developments
11.15 LungLifeAI
11.15.1 LungLifeAI Company Details
11.15.2 LungLifeAI Business Overview
11.15.3 LungLifeAI Artificial Intelligence (AI) in Cancer Introduction
11.15.4 LungLifeAI Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.15.5 LungLifeAI Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Surgery
Table 3. Key Players of Radiotherapy
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Immunotherapy
Table 6. Key Players of Phototherapy
Table 7. Key Players of Gene Therapy
Table 8. Key Players of Sonodynamic Therapy
Table 9. Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 10. Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Artificial Intelligence (AI) in Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Artificial Intelligence (AI) in Cancer Market Share by Region (2018-2023)
Table 13. Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 14. Global Artificial Intelligence (AI) in Cancer Market Share by Region (2024-2029)
Table 15. Artificial Intelligence (AI) in Cancer Market Trends
Table 16. Artificial Intelligence (AI) in Cancer Market Drivers
Table 17. Artificial Intelligence (AI) in Cancer Market Challenges
Table 18. Artificial Intelligence (AI) in Cancer Market Restraints
Table 19. Global Artificial Intelligence (AI) in Cancer Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Artificial Intelligence (AI) in Cancer Revenue Share by Players (2018-2023)
Table 21. Global Top Artificial Intelligence (AI) in Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence (AI) in Cancer as of 2022)
Table 22. Global Artificial Intelligence (AI) in Cancer Industry Ranking 2021 VS 2022 VS 2023
Table 23. Global 5 Largest Players Market Share by Artificial Intelligence (AI) in Cancer Revenue (CR5 and HHI) & (2018-2023)
Table 24. Global Key Players of Artificial Intelligence (AI) in Cancer, Headquarters and Area Served
Table 25. Global Key Players of Artificial Intelligence (AI) in Cancer, Product and Application
Table 26. Global Key Players of Artificial Intelligence (AI) in Cancer, Product and Application
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Type (2018-2023)
Table 30. Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 31. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Type (2024-2029)
Table 32. Global Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Artificial Intelligence (AI) in Cancer Revenue Share by Application (2018-2023)
Table 34. Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 35. Global Artificial Intelligence (AI) in Cancer Revenue Share by Application (2024-2029)
Table 36. North America Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 37. North America Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 38. North America Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 39. North America Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 40. North America Artificial Intelligence (AI) in Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. North America Artificial Intelligence (AI) in Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 42. North America Artificial Intelligence (AI) in Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 43. Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 44. Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 45. Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 46. Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 47. Europe Artificial Intelligence (AI) in Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 49. Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 50. China Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 51. China Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 52. China Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 53. China Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 55. Asia Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 56. Asia Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 57. Asia Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 58. Asia Artificial Intelligence (AI) in Cancer Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 59. Asia Artificial Intelligence (AI) in Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 60. Asia Artificial Intelligence (AI) in Cancer Market Size by Region (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 66. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 68. IBM Company Details
Table 69. IBM Business Overview
Table 70. IBM Artificial Intelligence (AI) in Cancer Product
Table 71. IBM Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 72. IBM Recent Developments
Table 73. Microsoft Company Details
Table 74. Microsoft Business Overview
Table 75. Microsoft Artificial Intelligence (AI) in Cancer Product
Table 76. Microsoft Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 77. Microsoft Recent Developments
Table 78. NVIDIA Company Details
Table 79. NVIDIA Business Overview
Table 80. NVIDIA Artificial Intelligence (AI) in Cancer Product
Table 81. NVIDIA Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 82. NVIDIA Recent Developments
Table 83. Intel Company Details
Table 84. Intel Business Overview
Table 85. Intel Artificial Intelligence (AI) in Cancer Product
Table 86. Intel Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 87. Intel Recent Developments
Table 88. GE Healthcare Company Details
Table 89. GE Healthcare Business Overview
Table 90. GE Healthcare Artificial Intelligence (AI) in Cancer Product
Table 91. GE Healthcare Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 92. GE Healthcare Recent Developments
Table 93. Johnson & Johnson Company Details
Table 94. Johnson & Johnson Business Overview
Table 95. Johnson & Johnson Artificial Intelligence (AI) in Cancer Product
Table 96. Johnson & Johnson Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 97. Johnson & Johnson Recent Developments
Table 98. Cancer Center.ai Company Details
Table 99. Cancer Center.ai Business Overview
Table 100. Cancer Center.ai Artificial Intelligence (AI) in Cancer Product
Table 101. Cancer Center.ai Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 102. Cancer Center.ai Recent Developments
Table 103. Digital Reasoning Company Details
Table 104. Digital Reasoning Business Overview
Table 105. Digital Reasoning Artificial Intelligence (AI) in Cancer Product
Table 106. Digital Reasoning Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 107. Digital Reasoning Recent Developments
Table 108. Varian Medical Systems Company Details
Table 109. Varian Medical Systems Business Overview
Table 110. Varian Medical Systems Artificial Intelligence (AI) in Cancer Product
Table 111. Varian Medical Systems Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 112. Varian Medical Systems Recent Developments
Table 113. Niramai Company Details
Table 114. Niramai Business Overview
Table 115. Niramai Artificial Intelligence (AI) in Cancer Product
Table 116. Niramai Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 117. Niramai Recent Developments
Table 118. Densitas Company Details
Table 119. Densitas Business Overview
Table 120. Densitas Artificial Intelligence (AI) in Cancer Product
Table 121. Densitas Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 122. Densitas Recent Developments
Table 123. MammoScreen Company Details
Table 124. MammoScreen Business Overview
Table 125. MammoScreen Artificial Intelligence (AI) in Cancer Product
Table 126. MammoScreen Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 127. MammoScreen Recent Developments
Table 128. MVision AI Company Details
Table 129. MVision AI Business Overview
Table 130. MVision AI Artificial Intelligence (AI) in Cancer Product
Table 131. MVision AI Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 132. MVision AI Recent Developments
Table 133. Volpara Company Details
Table 134. Volpara Business Overview
Table 135. Volpara Artificial Intelligence (AI) in Cancer Product
Table 136. Volpara Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 137. Volpara Recent Developments
Table 138. LungLifeAI Company Details
Table 139. LungLifeAI Business Overview
Table 140. LungLifeAI Artificial Intelligence (AI) in Cancer Product
Table 141. LungLifeAI Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 142. LungLifeAI Recent Developments
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 1. Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Surgery
Table 3. Key Players of Radiotherapy
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Immunotherapy
Table 6. Key Players of Phototherapy
Table 7. Key Players of Gene Therapy
Table 8. Key Players of Sonodynamic Therapy
Table 9. Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 10. Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Artificial Intelligence (AI) in Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Artificial Intelligence (AI) in Cancer Market Share by Region (2018-2023)
Table 13. Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 14. Global Artificial Intelligence (AI) in Cancer Market Share by Region (2024-2029)
Table 15. Artificial Intelligence (AI) in Cancer Market Trends
Table 16. Artificial Intelligence (AI) in Cancer Market Drivers
Table 17. Artificial Intelligence (AI) in Cancer Market Challenges
Table 18. Artificial Intelligence (AI) in Cancer Market Restraints
Table 19. Global Artificial Intelligence (AI) in Cancer Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Artificial Intelligence (AI) in Cancer Revenue Share by Players (2018-2023)
Table 21. Global Top Artificial Intelligence (AI) in Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence (AI) in Cancer as of 2022)
Table 22. Global Artificial Intelligence (AI) in Cancer Industry Ranking 2021 VS 2022 VS 2023
Table 23. Global 5 Largest Players Market Share by Artificial Intelligence (AI) in Cancer Revenue (CR5 and HHI) & (2018-2023)
Table 24. Global Key Players of Artificial Intelligence (AI) in Cancer, Headquarters and Area Served
Table 25. Global Key Players of Artificial Intelligence (AI) in Cancer, Product and Application
Table 26. Global Key Players of Artificial Intelligence (AI) in Cancer, Product and Application
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Type (2018-2023)
Table 30. Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 31. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Type (2024-2029)
Table 32. Global Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Artificial Intelligence (AI) in Cancer Revenue Share by Application (2018-2023)
Table 34. Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 35. Global Artificial Intelligence (AI) in Cancer Revenue Share by Application (2024-2029)
Table 36. North America Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 37. North America Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 38. North America Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 39. North America Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 40. North America Artificial Intelligence (AI) in Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. North America Artificial Intelligence (AI) in Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 42. North America Artificial Intelligence (AI) in Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 43. Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 44. Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 45. Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 46. Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 47. Europe Artificial Intelligence (AI) in Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 49. Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 50. China Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 51. China Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 52. China Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 53. China Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 55. Asia Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 56. Asia Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 57. Asia Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 58. Asia Artificial Intelligence (AI) in Cancer Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 59. Asia Artificial Intelligence (AI) in Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 60. Asia Artificial Intelligence (AI) in Cancer Market Size by Region (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 66. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 68. IBM Company Details
Table 69. IBM Business Overview
Table 70. IBM Artificial Intelligence (AI) in Cancer Product
Table 71. IBM Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 72. IBM Recent Developments
Table 73. Microsoft Company Details
Table 74. Microsoft Business Overview
Table 75. Microsoft Artificial Intelligence (AI) in Cancer Product
Table 76. Microsoft Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 77. Microsoft Recent Developments
Table 78. NVIDIA Company Details
Table 79. NVIDIA Business Overview
Table 80. NVIDIA Artificial Intelligence (AI) in Cancer Product
Table 81. NVIDIA Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 82. NVIDIA Recent Developments
Table 83. Intel Company Details
Table 84. Intel Business Overview
Table 85. Intel Artificial Intelligence (AI) in Cancer Product
Table 86. Intel Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 87. Intel Recent Developments
Table 88. GE Healthcare Company Details
Table 89. GE Healthcare Business Overview
Table 90. GE Healthcare Artificial Intelligence (AI) in Cancer Product
Table 91. GE Healthcare Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 92. GE Healthcare Recent Developments
Table 93. Johnson & Johnson Company Details
Table 94. Johnson & Johnson Business Overview
Table 95. Johnson & Johnson Artificial Intelligence (AI) in Cancer Product
Table 96. Johnson & Johnson Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 97. Johnson & Johnson Recent Developments
Table 98. Cancer Center.ai Company Details
Table 99. Cancer Center.ai Business Overview
Table 100. Cancer Center.ai Artificial Intelligence (AI) in Cancer Product
Table 101. Cancer Center.ai Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 102. Cancer Center.ai Recent Developments
Table 103. Digital Reasoning Company Details
Table 104. Digital Reasoning Business Overview
Table 105. Digital Reasoning Artificial Intelligence (AI) in Cancer Product
Table 106. Digital Reasoning Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 107. Digital Reasoning Recent Developments
Table 108. Varian Medical Systems Company Details
Table 109. Varian Medical Systems Business Overview
Table 110. Varian Medical Systems Artificial Intelligence (AI) in Cancer Product
Table 111. Varian Medical Systems Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 112. Varian Medical Systems Recent Developments
Table 113. Niramai Company Details
Table 114. Niramai Business Overview
Table 115. Niramai Artificial Intelligence (AI) in Cancer Product
Table 116. Niramai Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 117. Niramai Recent Developments
Table 118. Densitas Company Details
Table 119. Densitas Business Overview
Table 120. Densitas Artificial Intelligence (AI) in Cancer Product
Table 121. Densitas Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 122. Densitas Recent Developments
Table 123. MammoScreen Company Details
Table 124. MammoScreen Business Overview
Table 125. MammoScreen Artificial Intelligence (AI) in Cancer Product
Table 126. MammoScreen Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 127. MammoScreen Recent Developments
Table 128. MVision AI Company Details
Table 129. MVision AI Business Overview
Table 130. MVision AI Artificial Intelligence (AI) in Cancer Product
Table 131. MVision AI Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 132. MVision AI Recent Developments
Table 133. Volpara Company Details
Table 134. Volpara Business Overview
Table 135. Volpara Artificial Intelligence (AI) in Cancer Product
Table 136. Volpara Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 137. Volpara Recent Developments
Table 138. LungLifeAI Company Details
Table 139. LungLifeAI Business Overview
Table 140. LungLifeAI Artificial Intelligence (AI) in Cancer Product
Table 141. LungLifeAI Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023) & (US$ Million)
Table 142. LungLifeAI Recent Developments
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Artificial Intelligence (AI) in Cancer Market Share by Type: 2022 VS 2029
Figure 3. Surgery Features
Figure 4. Radiotherapy Features
Figure 5. Chemotherapy Features
Figure 6. Immunotherapy Features
Figure 7. Phototherapy Features
Figure 8. Gene Therapy Features
Figure 9. Sonodynamic Therapy Features
Figure 10. Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 11. Global Artificial Intelligence (AI) in Cancer Market Share by Application: 2022 VS 2029
Figure 12. Diagnosis Case Studies
Figure 13. Therapy Case Studies
Figure 14. Prognosis Case Studies
Figure 15. Health Management Case Studies
Figure 16. Research Case Studies
Figure 17. Artificial Intelligence (AI) in Cancer Report Years Considered
Figure 18. Global Artificial Intelligence (AI) in Cancer Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 19. Global Artificial Intelligence (AI) in Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 20. Global Artificial Intelligence (AI) in Cancer Market Share by Region: 2022 VS 2029
Figure 21. Global Artificial Intelligence (AI) in Cancer Market Share by Players in 2022
Figure 22. Global Top Artificial Intelligence (AI) in Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence (AI) in Cancer as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by Artificial Intelligence (AI) in Cancer Revenue in 2022
Figure 24. North America Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. North America Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
Figure 26. North America Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
Figure 27. North America Artificial Intelligence (AI) in Cancer Market Share by Country (2018-2029)
Figure 28. United States Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Canada Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Europe Artificial Intelligence (AI) in Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 31. Europe Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
Figure 32. Europe Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
Figure 33. Europe Artificial Intelligence (AI) in Cancer Market Share by Country (2018-2029)
Figure 34. Germany Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. France Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. U.K. Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Italy Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Russia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Nordic Countries Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. China Artificial Intelligence (AI) in Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 41. China Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
Figure 42. China Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
Figure 43. Asia Artificial Intelligence (AI) in Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 44. Asia Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
Figure 45. Asia Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
Figure 46. Asia Artificial Intelligence (AI) in Cancer Market Share by Region (2018-2029)
Figure 47. Japan Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. South Korea Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. China Taiwan Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Southeast Asia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. India Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Australia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 54. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
Figure 55. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
Figure 56. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Share by Country (2018-2029)
Figure 57. Brazil Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Mexico Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Turkey Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Saudi Arabia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 61. Israel Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 62. GCC Countries Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 63. IBM Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 64. Microsoft Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 65. NVIDIA Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 66. Intel Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 67. GE Healthcare Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 68. Johnson & Johnson Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 69. Cancer Center.ai Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 70. Digital Reasoning Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 71. Varian Medical Systems Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 72. Niramai Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 73. Densitas Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 74. MammoScreen Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 75. MVision AI Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 76. Volpara Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 77. LungLifeAI Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Figure 1. Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Artificial Intelligence (AI) in Cancer Market Share by Type: 2022 VS 2029
Figure 3. Surgery Features
Figure 4. Radiotherapy Features
Figure 5. Chemotherapy Features
Figure 6. Immunotherapy Features
Figure 7. Phototherapy Features
Figure 8. Gene Therapy Features
Figure 9. Sonodynamic Therapy Features
Figure 10. Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 11. Global Artificial Intelligence (AI) in Cancer Market Share by Application: 2022 VS 2029
Figure 12. Diagnosis Case Studies
Figure 13. Therapy Case Studies
Figure 14. Prognosis Case Studies
Figure 15. Health Management Case Studies
Figure 16. Research Case Studies
Figure 17. Artificial Intelligence (AI) in Cancer Report Years Considered
Figure 18. Global Artificial Intelligence (AI) in Cancer Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 19. Global Artificial Intelligence (AI) in Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 20. Global Artificial Intelligence (AI) in Cancer Market Share by Region: 2022 VS 2029
Figure 21. Global Artificial Intelligence (AI) in Cancer Market Share by Players in 2022
Figure 22. Global Top Artificial Intelligence (AI) in Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence (AI) in Cancer as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by Artificial Intelligence (AI) in Cancer Revenue in 2022
Figure 24. North America Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. North America Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
Figure 26. North America Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
Figure 27. North America Artificial Intelligence (AI) in Cancer Market Share by Country (2018-2029)
Figure 28. United States Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Canada Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Europe Artificial Intelligence (AI) in Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 31. Europe Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
Figure 32. Europe Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
Figure 33. Europe Artificial Intelligence (AI) in Cancer Market Share by Country (2018-2029)
Figure 34. Germany Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. France Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. U.K. Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Italy Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Russia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Nordic Countries Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. China Artificial Intelligence (AI) in Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 41. China Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
Figure 42. China Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
Figure 43. Asia Artificial Intelligence (AI) in Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 44. Asia Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
Figure 45. Asia Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
Figure 46. Asia Artificial Intelligence (AI) in Cancer Market Share by Region (2018-2029)
Figure 47. Japan Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. South Korea Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. China Taiwan Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Southeast Asia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. India Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Australia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size YoY (2018-2029) & (US$ Million)
Figure 54. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
Figure 55. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
Figure 56. Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Share by Country (2018-2029)
Figure 57. Brazil Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Mexico Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Turkey Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Saudi Arabia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 61. Israel Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 62. GCC Countries Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 63. IBM Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 64. Microsoft Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 65. NVIDIA Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 66. Intel Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 67. GE Healthcare Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 68. Johnson & Johnson Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 69. Cancer Center.ai Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 70. Digital Reasoning Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 71. Varian Medical Systems Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 72. Niramai Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 73. Densitas Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 74. MammoScreen Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 75. MVision AI Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 76. Volpara Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 77. LungLifeAI Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2018-2023)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
